Treating rare breast cancer with radiation therapy may lower recurrence rate

Jul 11, 2008

Patients with a rare type of breast cancer may benefit from receiving radiation therapy in addition to surgery to prevent recurrence, according to a study in the July issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

Phyllodes tumors are rare breast tumors that develop in the connective tissue of the breast, as opposed to more common carcinomas, which develop in the ducts or lobules of the breast. Most patients are treated for phyllodes tumors with either a lumpectomy or mastectomy, with only a small fraction of patients receiving radiation therapy.

Traditionally, adjuvant radiation therapy is recommended for cancer patients with local recurrence risks of 15 percent or greater, but the value of adjuvant radiation therapy has not been extensively studied for phyllodes tumors because they are so rare.

Researchers at the Division of Radiation Oncology, Department of Medical Physics, and Department of General and Oncologic Surgery at City of Hope National Medical Center in Duarte, Calif., sought to determine the local recurrence rates of phyllodes tumors based on tumor size and the type of surgery performed and whether adjuvant radiation therapy should be considered as a treatment for some phyllodes tumor patients to reduce their local recurrence rate.

"Typically these tumors are treated well by surgery alone. However, local recurrences are not uncommon," Richard Pezner, M.D., lead author of the study and a radiation oncologist at City of Hope National Medical Center in Duarte, Calif., said.

The study authors reviewed records of 478 patients with malignant phyllodes tumors who were treated between March 1964 and August 2005. The records came from the IMPAC National Oncology Database, which consists of tumor registries from 130 hospitals.

The researchers found that the risk of local recurrence for phyllodes tumors was related to tumor size and the type of surgery received. They determined that adjuvant radiation therapy should be evaluated for phyllodes tumor patients who received lumpectomies for tumors at least 2 centimeters in size or a mastectomy for tumors at least 10 centimeters in size to reduce the risk of recurrence.

Source: American Society for Therapeutic Radiology and Oncology

Explore further: Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense

add to favorites email to friend print save as pdf

Related Stories

A look at earthquake's impact on California region

6 hours ago

A strong earthquake rattled a swath of Northern California's wine country in the early hours of Sunday morning, unleashing most of its damage on the city of Napa in the heart of the vineyard-studded region.

Amazon to pay $1bn for gaming site Twitch: report

6 hours ago

Amazon is buying the videogame platform Twitch for $1 billion, bringing it access to millions of people who watch games being played on the site, The Wall Street Journal reported Monday.

Recommended for you

Better classification to improve treatments for breast cancer

3 hours ago

Breast cancer can be classified into ten different subtypes, and scientists have developed a tool to identify which is which. The research, published in the journal Genome Biology, could improve treatments and targeting of tre ...

Risk of diabetes up in hodgkin's lymphoma survivors

5 hours ago

(HealthDay)—Para-aortic radiation correlates with increased diabetes mellitus (DM) risk for Hodgkin's lymphoma (HL) survivors, according to a study published online Aug. 25 in the Journal of Clinical On ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
not rated yet Jul 12, 2008
X-ray is one of the best ways to disrupt the orderly operation of a cell and produce cancer!